Improving Outcomes for Patients with High-Risk Myeloma Via Prospective Trial Evidence: The Myeloma UK Nine Optimum Trial

Metadata

Authors/Creators:	Sherborne, AL Shah, V Ellis, S Begum, F Kendall, J Johnson, DC Owen, RG Drayson, MT Flanagan, L Sherratt, D Gregory, WM https://orcid.org/0000-0003-2641-8416 Jackson, G Pratt, G Cook, G Hinsley, S https://orcid.org/0000-0001-6903-4688 Brown, S Jenner, MW Kaiser, MF
Copyright, Publisher and Additional Information:	© 2017 by The American Society of Hematology. This is an author produced version of a paper published in Blood. Uploaded in accordance with the publisher's self-archiving policy.
Dates:	Accepted: 2 August 2017 Published: 7 December 2017
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Depositing User:	Symplectic Publications
Date Deposited:	18 Dec 2018 15:12
Last Modified:	29 Jun 2020 13:36
Status:	Published
Publisher:	American Society of Hematology
Related URLs:	Author

CORE (COnnecting REpositories)